1. Korean Food and Drug Administration: Cell therapy. Korean Food and Drug Administration Rules and Regulations. Seoul, Korea: Food and Drug Administration, Chapter 2, Section 12
2. Arnoczky SP: Building a meniscus. Biologic considerations. Clin Orthop Relat Res. 1999, 367 (Suppl): S244-S253.
3. Barry FP: Mesenchymal stem cell therapy in joint disease. Novartis Found Symp. 2003, 249: 86-96.
4. Zhang HN, Li L, Leng P, Wang YZ, Lv CY: Uninduced adipose-derived stem cells repair the defect of full-thickness hyaline cartilage. Chin J Traumatol. 2009, 12: 92-97.
5. Centeno CJ, Buse D, Kisiday J, Keohan C, Freeman M, Karli D: Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008, 11: 343-353.